Safety Study of Tecadenoson to Treat Atrial Fibrillation

Clinical trial NCT00713401 · COMPLETED

Trial details

NCT number: NCT00713401
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2008-02-01
Primary completion: 2008-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.